Novo Nordisk (United States)
companySeattle, Washington, United States
Research output, citation impact, and the most-cited recent papers from Novo Nordisk (United States) (United States). Aggregated across the NobleBlocks index of 300M+ scholarly works.
Total works
2.4K
Citations
197.4K
h-index
215
i10-index
2.4K
Also known as
Novo Nordisk (United States)
Top research topics
Diabetes Treatment and Management(515)Diabetes Management and Research(332)Hemophilia Treatment and Research(213)Diabetes, Cardiovascular Risks, and Lipoproteins(159)Pancreatic function and diabetes(150)Bariatric Surgery and Outcomes(133)Metabolism, Diabetes, and Cancer(117)Diabetes and associated disorders(100)Hyperglycemia and glycemic control in critically ill and hospitalized patients(87)Growth Hormone and Insulin-like Growth Factors(85)Pharmacology and Obesity Treatment(83)Genetic Associations and Epidemiology(69)Diabetes Management and Education(68)Platelet Disorders and Treatments(57)Medication Adherence and Compliance(56)
Top-cited papers from Novo Nordisk (United States)
No indexed publications for this institution yet.